Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î]¿µ±¹, OHH ¼­ºñ½º ÀϹݾࡤÀü¹®¾à ³ª´² Á¦°ø
³»   ¿ë
Âü¿© ¿¬±¸¿ø ÀÓÀ翵 ½ÇÀå/±èÁøÀ̠åÀÓ¿¬±¸¿ø/Á¤µ¿¿í ºÎ¼±ÀÓ¿¬±¸¿ø
ÆíÁý ÀÌÁÖÇÏ ÁÖÀÓ¿¬±¸¿ø


<Áö³­È£¿¡ À̾>
1. ±¹³»¿Ü ÇöȲ ¹× »ç·ÊÁ¶»ç
2) ¿µ±¹
°¡) OOH(Out of hours) medicines
¿µ±¹ÀÇ °æ¿ì NHS(National Health Service)¿¡¼­´Â ÀϹÝÀÇ(GP, General Practitioner) Áø·áÀÇ Á¤±Ô ¿µ¾÷½Ã°£ ¿Ü¿¡ ¾àÀÌ ¼ÒÁøµÇ¾î ±ä±ÞÇϰԠÇÊ¿äÇÑ °æ¿ì, ¿ø·¡ ÁÖ¼ÒÁö¿Í ¸Ö¸® Àִ °æ¿ì¿¡µµ ½Å¼ÓÇϰԠÀÀ±Þ °ø±Þ ¹ÞÀ» ¼ö Àִ ¹æ¹ýÀ» ¼Ò°³Çϰí ÀÖ´Ù. 

À̸¦ Out-of-hours medicines¶ó°í Çϸç ÀϹÝÀǾàǰÀÌ ÇÊ¿äÇÑ °æ¿ì(ó¹æÀüÀÌ Çʿ䠾ø´Â °æ¿ì), Àü¹®ÀǾàǰÀÌ ÇÊ¿äÇÑ °æ¿ì(ó¹æÀüÀÌ ÇÊ¿äÇÑ °æ¿ì)·Î ³ª´² ¾È³»Çϰí ÀÖ´Ù.

¨ç ÀϹÝÀǾàǰÀÌ ÇÊ¿äÇÑ °æ¿ì(ó¹æÀüÀÌ Çʿ䠾ø´Â °æ¿ì)
ÁøÅëÁ¦³ª Á¦»êÁ¦ µî ºñ󹿠ÀǾàǰÀÌ ÇÊ¿äÇÑ °æ¿ì¿¡ ¿µ¾÷ ÁßÀΠ¾à±¹À» Ã£À» ¼ö ¾ø´Ù¸é ½´ÆÛ¸¶ÄÏ, ½Å¹® °¡ÆÇ´ë, °æÂû¼­¿¡¼­ ±âº»ÀûÀΠÁ¾·ùÀÇ ÀϹÝÀǾàǰÀ» Ã£À» ¼ö ÀÖ´Ù. ÀÌ·¯ÇÑ Àå¼ÒµéÀº ÀϹÝÀûÀ¸·Î ¾à±¹º¸´Ù ±ä ¿µ¾÷½Ã°£À» °¡Áö°í ÀÖ´Ù.

¨è Àü¹®ÀǾàǰÀÌ ÇÊ¿äÇÑ °æ¿ì-ó¹æÀüÀ» °¡Áö°í Àִ °æ¿ì
±ÞÈ÷ ¾àÀÌ ÇÊ¿äÇÑ °æ¿ì¿¡ Ã³¹æÀüÀº ÀÖÁö¸¸ ´Ù´Ï´ø ¾à±¹ÀÌ ¹®À» ´Ý¾Ò´Ù¸é ÇØ´ç ÀǾàǰÀÇ Àç°í°¡ Àִ ´Ù¸¥ ¾à±¹¿¡¼­ ¾àÀ» ¹ÞÀ» ¼ö ÀÖ´Ù. 

'NHS ¾à±¹ °Ë»ö ¼­ºñ½º'À» »ç¿ëÇϸ頱Ùó¿¡ À§Ä¡ÇÑ ¾à±¹µé Áß ÀÚÁ¤±îÁö È¤Àº °øÈÞÀÏ¿¡µµ ¿µ¾÷Çϴ ¾à±¹À» °Ë»öÇØ ¼±ÅÃÇÒ ¼ö ÀÖ´Ù. 


¨é Àü¹®ÀǾàǰÀÌ ÇÊ¿äÇÑ °æ¿ì-ó¹æÀüÀÌ ¾ø´Â °æ¿ì
¸¸¾à Ã³¹æ¹ÞÀº ÀǾàǰÀÌ ¶³¾îÁ³´Âµ¥ °¡Áö°í Àִ ó¹æÀüÀÌ ¾ø´Ù¸é ¾à±¹¿¡¼­ Ã³¹æÀü ¾øÀÌ ÀÀ±Þó¹æÀ» ¹ÞÀ» ¼ö ÀÖ´Ù. 

ÀÌ °æ¿ì ¸¸¾à Áý¿¡ Áö³­ Ã³¹æÀü ¶Ç´Â ÀǾàǰ Æ÷ÀåÁö°¡ ÀÖ´Ù¸é ÇÔ²² °¡Áö°í °¡´Â °ÍÀÌ ÁÁ´Ù. ¾à»ç´Â ÀÀ±Þó¹æÀ» À§ÇؠȯÀÚ¸¦ ÀÎÅͺäÇϸ砾Ʒ¡ÀÇ »çÇ×µéÀ» È®ÀÎÇÑ´Ù.


¾à»ç´Â È¯ÀÚ¿¡°Ô Ã³¹æÀü ¾øÀÌ Àü¹®ÀǾàǰÀ» ÁÖ±â Àü À§ Áú¹®¿¡ ´ëÇÑ ´äº¯À» ¸ðµÎ ¾Ë¾Æ¾ß ÇÑ´Ù. ¶ÇÇÑ ¸¸¾à ÀǾàǰ°ú ¿ë·®À̠ȯÀÚ¿¡°Ô ºÎÀûÀýÇÏ´Ù°í °í·ÁµÇ¸é È¯ÀÚ¿¡°Ô ÀǾàǰÀ» ÁÖÁö ¾ÊÀ» ¼öµµ ÀÖ´Ù. 

Æò»ó½Ã¿¡´Â ÀǾàǰ¿¡ ´ëÇÑ ºñ¿ëÀ» ÁöºÒÇÏÁö ¾Ê´õ¶óµµ ÀÀ±Þó¹æÀ» ¹Þ´Â °æ¿ì¿¡´Â ÇØ´ç ¼­ºñ½º¿Í ÀǾàǰ¿¡ ´ëÇÑ ºñ¿ëÀ» ÁöºÒÇϰԠµÉ ¼ö ÀÖÀ¸¸ç À̴ ¾à±¹¿¡ µû¶ó ´Ù¸£´Ù. 

³ª) ¾à±¹ÀÇ Out of Hours(OOH) Service
NHS´Â Çâ»óµÈ ¼­ºñ½º(Enhanced Service)ÀÇ Çϳª·Î Out of Hours Service¸¦ Á¦½ÃÇØ ÇØ´ç »ç¾÷ÀÇ ½ÃÇà ¿©ºÎ¸¦ °¢ Áö¿ª¾à»çÀ§¿øÈ¸(Local Pharmaceutical Committees)¿¡ À§ÀÓÇϰí ÀÖ´Ù. OOH ¼­ºñ½º¸¦ ÁøÇàÇϴ ¾à±¹Àº »ç¶÷µéÀÌ ÀϹÝÀûÀΠ¿µ¾÷½Ã°£ ¿Ü¿¡µµ ÀǾàǰ¿¡ ¹Ù·Î Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï ¾à±¹À» ¿¬ÀåµÈ ½Ã°£µ¿¾È ¿µ¾÷ÇÑ´Ù. 

ÀÌ OOH ¼­ºñ½º´Â Çʼö ¼­ºñ½º(Essential Service)³»¿¡¼­ Á¦°øµÇ´Â Á¶Á¦ ¼­ºñ½º ¹Ù±ù ¶Ç´Â »óÀ§ÀÇ ¹üÀ§¿¡¼­ Á¦°øµÇ´Â ¼­ºñ½ºÀÌ´Ù. OOH ¼­ºñ½ºÀÇ ¼¼ºÎÀûÀΠ³»¿ëÀº °¢ LPC º°·Î ´Ù¸£´Ù.

¿µ±¹¿¡¼­ OOH ¼­ºñ½º¸¦ ¿î¿µ ÁßÀΠLPC´Â ±Û·Î½ºÅͼÅ, ³ëÆÃ¾ö¼Å, ¾Æº» ¼¼ °³ÀÇ LPCÀÌ´Ù. ³ëÆÃ¾ö¼Å ÁÖ¿¡¼­´Â ¹Ù¼¼Æ²·¯ ±¸¿¡¼­¸¸, ¾Æº» ÁÖ¿¡¼­´Â ºê¸®½ºÆ² ±¸¿ª¿¡¼­¸¸ ÇÑÁ¤ÀûÀ¸·Î ¼­ºñ½º¸¦ ¿î¿µÇϰí ÀÖ´Ù. <´ÙÀ½È£¿¡ °è¼Ó>

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
129 [´ëÇѾà»çÀú³Î]°ø°ø½É¾ß¾à±¹, »ç¾÷ È®´ë À§ÇØ ¿î¿µ¡¤ÆíÀÇ °³¼± ÇÊ¿ä ÀÌÁÖÇÏ 2021-09-23 900
128 [´ëÇѾà»çÀú³Î]½É¾ß½Ã°£ ¾à±¹ ÀÌ¿ë '¸¸Á·ÇÑ´Ù' 93.5% ÀÌÁÖÇÏ 2021-09-23 779
127 [´ëÇѾà»çÀú³Î]¿µ±¹, OHH ¼­ºñ½º ÀϹݾࡤÀü¹®¾à ³ª´² Á¦°ø ÀÌÁÖÇÏ 2021-09-23 758
126 [´ëÇѾà»çÀú³Î]È£ÁÖ ¹ãÀ» ¹àÈ÷´Â 'Supercare' ¾à±¹ ÀÌÁÖÇÏ 2021-09-23 764
125 [ÀǾàǰÁ¤Ã¥¸®Æ÷Æ®]ÀÀ´äÀÚ 94.3% µµÀÔ Âù¼º¡¦Àü¹®Àû »ó´ã Àý½Ç ÀÌÁÖÇÏ 2021-09-23 250
124 [´ëÇѾà»çÀú³Î] ¾à ±¸ÀÔ ½Ã ¾à»ç¿Í »ó´ãÀÌ Áß¿ä 85% ÀÌÁö¿¬ 2021-08-10 520
123 [´ëÇѾà»çÀú³Î] ÀǾàǰ ¾ÈÀü»ç¿ë ±³À° 'µµ¿òµÆ´Ù' 98% ÀÌÁö¿¬ 2021-08-02 459
122 [´ëÇѾà»çÀú³Î] ¾ÆÆí ÇÔÀ¯ 'Á¤ÅëÆí' ÅëÁõ ¸¸º´ÅëÄ¡¾àó·³ »ç¿ë ÀÌÁö¿¬ 2021-08-02 506
121 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠó¹æÀǾàǰ È¿°ú ½Å·Ú ´õ ³ô¾Æ ÀÌÁö¿¬ 2021-07-21 448
120 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠÀǾàǰ Àνİú »ç¿ë ÇöȲÀº? ÀÌÁö¿¬ 2021-07-14 390
119 [´ëÇѾà»çÀú³Î] "ºÎÀÛ¿ë °æÇè 98% Áõ»ó ½Å°í¾ÈÇØ" ºÒ°¨Áõ ½É°¢ ÀÌÁö¿¬ 2021-07-07 464
118 [´ëÇѾà»çÀú³Î] ¾ÈÀü»óºñÀǾàǰ ±¸ÀÔ ¿äÀÏ ÁÖ¸» '50.3%' Â÷Áö ÀÌÁö¿¬ 2021-06-29 452
117 [´ëÇѾà»çÀú³Î] ±¹¹Î 90% 1³â°£ ÆíÀÇÁ¡ »óºñ¾à ÃÖ´ë 5ȸ ±¸ÀÔ ÀÌÁö¿¬ 2021-06-22 485
116 [´ëÇѾà»çÀú³Î] ÆíÀÇÁ¡ ºøÀå Ç®¸®ÀÚ ½ñ¾ÆÁø °¨±â¾à¡¤ÁøÅëÁ¦ ÀÌÁö¿¬ 2021-06-16 433
115 [´ëÇѾà»çÀú³Î] Áö¿ª¾à±¹ '»ý¸íÁöÅ´ÀÌ' ¿ªÇÒ ¼öÇà °ü½É ³ôÇû´Ù ÀÌÁö¿¬ 2021-06-09 441

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»